Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in AV Graft Patients (AVeVA)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.

Also called NCT02790606

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 110 participants (enrolled count) (from the registry)
Sponsor
  • C. R. Bard Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02790606
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02790606. Allocation not applicable; no masking; primary purpose treatment. Start 2016-07 (actual); primary completion 2017-08 (actual). Results posted on 2019-02-26.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in AV Graft Patients (AVeVA)
Acronym
AVeVA
Condition
Stenosis
Condition
Restenosis
Intervention (Device)
Covera(TM) Vascular Covered Stent
Lead sponsor
C. R. Bard (class: industry)

Record details

Record id
cardio:ct-nct02790606
Content hash
f35037d0b46e1733fb54c756f3ffde8f6d0982fbcd409210574e966e87d3d3a5